Slide 1: The BIOLASE Total Solution
PAGE 1 The BIOLASE Total Solution Fred Furry, CFO October 4, 2012 Nasdaq: BIOL Exhibit 99.1
Slide 2: Safe Harbor Statement
The BIOLASE Total Solution PAGE 2 Safe Harbor Statement This presentation may contain forward-looking statements that are based on our current expectations, estimates and projections about our industry as well as management’s beliefs and assumptions. Words such as “anticipates,” “expects,” “intends,
Slide 3: What is Waterlase?
PAGE 3 The BIOLASE Total Solution Conventional Surgical Devices include the scalpel, high speed drill, electrosurge, electric bone saws, and heat generating lasers. What is Waterlase? BIOLASE has invented an optimized a biological method to cut tissue. Waterlase is a bilogical method to cut tissue w
Slide 4: BIOLASE: Company Overview
PAGE 4 The BIOLASE Total Solution • BIOLASE is a medical technology company that develops, manufactures, and markets dental lasers. • BIOLASE also markets and distributes dental imaging equipment, intra- oral scanners, and other products designed for procedures in dentistry and medicine. • 2011 GAAP
Slide 5: BIOLASE: Key Milestones
PAGE 5 The BIOLASE Total Solution BIOLASE: Key Milestones 1998 FDA clearance received for all-tissue Waterlase technology; began selling Waterlase. 2004 Introduced the ezLase, our first soft-tissue diode laser. 2006 Released the Waterlase MD Turbo, a significant advance in our technology. 2006 Enter
Slide 6: Revenues and Stock Price
$0,000 =F ¥Y- ¥¥- ¥- $70,000 $60,000 $50,000 $40,000 Revenues stock Price $30,000 $20,000 $10,000 so + 499s 1999) 2000 ©2001 ©2002-2003 4 2005-2008 «2007 «2008 «2009 :«-20LD | 2011-2012 Volume BIOLASE
Slide 7: Traditional Dentistry
PAGE 7 The BIOLASE Total Solution Traditional Dentistry Cavadenti, The Tooth Puller, by Caravaggio, circa 1608
Slide 8: BIOLASE: the World Leader in Laser Dentistry
PAGE 8 The BIOLASE Total Solution BIOLASE: the World Leader in Laser Dentistry Atraumatic Pediatric Tooth Extraction The aiming beam on the Waterlase does not cut the tissue or generate any heat. The tissue is cut biologically, with little or no pain, by energizing water at the molecular level. …wit
Slide 9: Current Line of BIOLASE Products
PAGE 9 The BIOLASE Total Solution Digital Imaging: We offer Cefla’s NewTom cone beam 3D imaging and a full line of BIOLASE DaVinci Imaging equipment, including the D3D CBCT. We also distribute 3Shape’s Trios intra-oral scanning device for digital impression-taking solutions. Diode soft-tissue dental
Slide 10: How It Works: Waterlase High Speed Cutting
PAGE 10 The BIOLASE Total Solution How It Works: Waterlase High Speed Cutting
Slide 11: Waterlase: Side by Side with Drill
PAGE 11 The BIOLASE Total Solution Waterlase: Side by Side with Drill
Slide 12: Waterlase: Soft Tissue Lingual Frenectomy
The BIOLASE Total Solution PAGE 12 Waterlase: Soft Tissue Lingual Frenectomy
Slide 13: $50B to $100B Waterlase Market Opportunity
PAGE 13 The BIOLASE Total Solution $50B to $100B Waterlase Market Opportunity Global market opportunity is immense…because the dental community is the largest medical community in the world. • 176,000 dentists in the US and Canada. ¹ • Over 1.2 million dentists in 134 countries and growing rapidly i
Slide 14: BIOLASE's Dominant Market Position: Hard-Tissue Laser Market
80% BIOLASE PAGE 14 The BIOLASE Total Solution BIOLASE’s Dominant Market Position Owning BIOLASE means owning the hard-tissue dental laser market… Source: BIOLASE Technology Licensing Reports
Slide 15: BIOLASE's Dominant Market Position: Overall Dental Laser Market
PAGE 15 45% BIOLASE The BIOLASE Total Solution Source: iData Research Inc. BIOLASE’s Dominant Market Position …and the overall dental laser market .
Slide 16: BIOLASE's Extensive Patent Portfolio
Issued & Active Pending Total PAGE 16 The BIOLASE Total Solution Current Status: BIOLASE has a tremendous IP portfolio with over issued and pending patents, 70% of which are related to our core Waterlase (Er,Cr:YSGG) technology and medical lasers. • Filing and maintenance costs are closely monitored
Slide 17: How Waterlase is Changing Dentistry
PAGE 17 The BIOLASE Total Solution How Waterlase is Changing Dentistry Pain free in many cases: • With no anesthesia, Waterlase increases efficiency and allows the dentist to work in multiple quadrants in a single visit. Less damage to the surrounding tissue. Speed of Waterlase now matches a high-sp
Slide 18: Eliminating the Risk of Cross Contamination
PAGE 18 The BIOLASE Total Solution Waterlase MD ™ reduced E. faecalist 2.86 times more effectively than NaOCl ³ Burs and Endo Files: • 15% of “sterilized” burs and up to 76% of “sterilized” endodontic files carry pathogenic micro-organisms. • Complex and rugged bur surface difficult to sterilize. •
Slide 19: Patented laser toothbrush, new lasers and imaging products
PAGE 19 The BIOLASE Total Solution Patented laser toothbrush for home use: • Development underway with The Proctor and Gamble Company to develop a laser toothbrush for home use that has the capability to whiten teeth, disinfect teeth and gums, bio-stimulate teeth and gums, and relieve pain. New lase
Slide 20: Opportunities to Expand Beyond Dentistry
PAGE 20 The BIOLASE Total Solution With our patented Waterlase and diode technologies, we have created technological platforms that have the ability to extend beyond dentistry: Ophthalmology: We hold issued and pending U.S. and International patents in four patent families in the field of ophthalmol
Slide 21: Opportunities to Expand Beyond Dentistry (Continued)
PAGE 21 The BIOLASE Total Solution We expect to expand our addressable markets in 2012 and 2013; these potential markets represent multi-billion dollar opportunities. Aesthetics: We have various FDA approvals for applications in oculoplastics, dermatology, and plastic surgery, and are currently inve
Slide 22: BIOLASE Today
PAGE 22 The BIOLASE Total Solution BIOLASE Today Company Headquarters in Irvine, California • Over 190 employees worldwide. • Sales offices in Floss (Germany), Madrid (Spain), Shanghai (China), and Mumbai (India), with expansion planned in Dubai (UAE), and Rio de Janero (Brazil). • Floss also has se
Slide 23: Investment Considerations
PAGE 23 The BIOLASE Total Solution Investment Considerations • Ongoing growth in sales and core product line under new distribution model • Addressing $50B-100B market opportunity • Growth drivers include: • Strong IP portfolio with additional patents pending • Strengthened financial situation • CEO